Yael Levy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Yael Levy has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
N. Segal
Kipper Institute of Immunology, Schneider Children's Medical Center of Israel, Petah Tiqva
3 shared publicationsY. L. Danon
Kipper Institute of Immunology, Schneider Children's Medical Center of Israel, Petah Tiqva
3 shared publicationsYehuda L. Danon
3 shared publicationsA. Broides
Kipper Institute of Immunology Schneider Children's Medical Center of Israel 14 Kaplan Street Petah Tiqva 49202 Israel Tel: 972‐3‐925 3652 Fax: 972‐3‐925 905
1 shared publication- Amos Etzioni
Technion
1 shared publication Ariel Koren
1 shared publication
Latest Publications
- 1 November 2010
- Vol. 12 (11) , 684-6
Soy allergy following early soy feeding in neonates.
B ACKGROUND:Feeding neonates with humanized milk formula in maternity hospitals may increase the prevalence of milk allergy in infants. However, prospective studies of the possible allergenic effect of very early soy-based formula feeding are lacking. To assess the prevalence of soy allergy in infants fed soy-based formula in the first 3 days of life. The study group included 982 healthy full-term infants born within a 7 month period at a hospital that routinely uses soy-based formula to supplement breastfeeding. In-hospital feeding was recorded and the parents were interviewed once monthly over the next 6 months regarding feeding practices and clinical symptoms suggesting soy allergy in the infant. Ninety-nine percent of the infants received soy-based formula supplement in hospital, and 33%-42% at home. No cases of immediate allergic reaction to soy or soy-induced enterocolitis were reported. The use of soy-based formula in the early neonatal period does not apparently increase the prevalence of soy allergy in infants followed for the next 6 months.
- 1 November 2010
- Vol. 12 (11) , 684-6
Soy allergy following early soy feeding in neonates.
B ACKGROUND:Feeding neonates with humanized milk formula in maternity hospitals may increase the prevalence of milk allergy in infants. However, prospective studies of the possible allergenic effect of very early soy-based formula feeding are lacking. To assess the prevalence of soy allergy in infants fed soy-based formula in the first 3 days of life. The study group included 982 healthy full-term infants born within a 7 month period at a hospital that routinely uses soy-based formula to supplement breastfeeding. In-hospital feeding was recorded and the parents were interviewed once monthly over the next 6 months regarding feeding practices and clinical symptoms suggesting soy allergy in the infant. Ninety-nine percent of the infants received soy-based formula supplement in hospital, and 33%-42% at home. No cases of immediate allergic reaction to soy or soy-induced enterocolitis were reported. The use of soy-based formula in the early neonatal period does not apparently increase the prevalence of soy allergy in infants followed for the next 6 months.
- 6 January 2009
- Published by Wiley in Pediatric Transplantation
- Vol. 13 (1) , 63-69
New‐onset post‐transplantation food allergy in children – Is it attributable only to the immunosuppressive protocol?
Abstract: New‐onset post‐transplantation food allergy has been described mainly after liver transplantation, and its pathogenesis was attributed to the immunomodulatory effects of tacrolimus therapy. The aim of the present study was to evaluate the association of food allergy with solid organ transplantation in our center. The medical records of children who underwent kidney transplantation and children who underwent liver or liver and kidney transplantation from 1986 to 2005 were reviewed. A total of 189 children (124 after kidney transplantation, 65 after liver or liver and kidney transplantation) received tacrolimus as part of the immunosuppressive regimen. New‐onset post‐transplantation food allergy was documented in four of them: two with liver transplants and two with combined kidney and liver transplants. The absence of new‐onset food allergy in the children with isolated kidney transplants is compatible with other reports in the literature. This study supports the concept that the functioning liver itself, and not only tacrolimus immunosuppression, is a main contributor to food allergy in this patient population.
- 6 January 2009
- Published by Wiley in Pediatric Transplantation
- Vol. 13 (1) , 63-69
New‐onset post‐transplantation food allergy in children – Is it attributable only to the immunosuppressive protocol?
Abstract: New‐onset post‐transplantation food allergy has been described mainly after liver transplantation, and its pathogenesis was attributed to the immunomodulatory effects of tacrolimus therapy. The aim of the present study was to evaluate the association of food allergy with solid organ transplantation in our center. The medical records of children who underwent kidney transplantation and children who underwent liver or liver and kidney transplantation from 1986 to 2005 were reviewed. A total of 189 children (124 after kidney transplantation, 65 after liver or liver and kidney transplantation) received tacrolimus as part of the immunosuppressive regimen. New‐onset post‐transplantation food allergy was documented in four of them: two with liver transplants and two with combined kidney and liver transplants. The absence of new‐onset food allergy in the children with isolated kidney transplants is compatible with other reports in the literature. This study supports the concept that the functioning liver itself, and not only tacrolimus immunosuppression, is a main contributor to food allergy in this patient population.
- 12 November 2007
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 18 (7) , 589-593
Lessons from the clinical course of IgE‐mediated cow milk allergy in Israel
Cow milk and milk products are the most common food products consumed in Israel; rates of allergy to cow milk exceed those of peanuts in infants and children. The aim of the present study was to evaluate retrospectively the clinical features and natural course of immunoglobulin (Ig) E‐mediated cow milk allergy (CMA) in Israel. Data of children diagnosed with CMA from 1995 to 2003, were collected regarding age at first and most recent reactions, symptoms and signs, family history of atopy, other allergic diseases, emergency department visits, hospitalizations, and treatment. Patients with transient CMA were compared to those with persistent CMA (≥3 yr old). The study group consisted of 105 patients, 43 with transient CMA (age range: 0.48–11 yr). The remaining 62 patients (age range: 3–16.5 yr) did not achieve tolerance to cow milk during the follow‐up period. No differences were found between the groups in mean age and symptoms and signs at the first allergic reaction and family history of atopy. Patients with persistent CMA had a higher rate of asthma than patients with transient CMA (61.2% vs. 18.6%, p < 0.001). Fifty patients with persistent CMA had 137 subsequent allergic reactions after diagnosis, 25% of the reactions were due to oral milk challenge at the clinic and 75% due to accidental exposure, of which 13% required an emergency department visit and 8%, hospitalization. Only 19% of the reactions were treated with epinephrine injection. In conclusion, in our experience, less than half of the children diagnosed with IgE‐mediated CMA during 9 yr, outgrew it. The patients with persistent CMA have a higher prevalence of asthma compared with the general population or to children with transient CMA. The high number of recurrent allergic reactions due to accidental exposure and the low rate of epinephrine usage in these patients point to a need for better education of patients and their families.
- 12 November 2007
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 18 (7) , 589-593
Lessons from the clinical course of IgE‐mediated cow milk allergy in Israel
Cow milk and milk products are the most common food products consumed in Israel; rates of allergy to cow milk exceed those of peanuts in infants and children. The aim of the present study was to evaluate retrospectively the clinical features and natural course of immunoglobulin (Ig) E‐mediated cow milk allergy (CMA) in Israel. Data of children diagnosed with CMA from 1995 to 2003, were collected regarding age at first and most recent reactions, symptoms and signs, family history of atopy, other allergic diseases, emergency department visits, hospitalizations, and treatment. Patients with transient CMA were compared to those with persistent CMA (≥3 yr old). The study group consisted of 105 patients, 43 with transient CMA (age range: 0.48–11 yr). The remaining 62 patients (age range: 3–16.5 yr) did not achieve tolerance to cow milk during the follow‐up period. No differences were found between the groups in mean age and symptoms and signs at the first allergic reaction and family history of atopy. Patients with persistent CMA had a higher rate of asthma than patients with transient CMA (61.2% vs. 18.6%, p < 0.001). Fifty patients with persistent CMA had 137 subsequent allergic reactions after diagnosis, 25% of the reactions were due to oral milk challenge at the clinic and 75% due to accidental exposure, of which 13% required an emergency department visit and 8%, hospitalization. Only 19% of the reactions were treated with epinephrine injection. In conclusion, in our experience, less than half of the children diagnosed with IgE‐mediated CMA during 9 yr, outgrew it. The patients with persistent CMA have a higher prevalence of asthma compared with the general population or to children with transient CMA. The high number of recurrent allergic reactions due to accidental exposure and the low rate of epinephrine usage in these patients point to a need for better education of patients and their families.
- 28 February 2007
- Published by Elsevier in Public Health
- Vol. 121 (2) , 144-147
Trends in adrenaline (EpiPen) dispensing in Israel in 1997–2004
- 28 February 2007
- Published by Elsevier in Public Health
- Vol. 121 (2) , 144-147
Trends in adrenaline (EpiPen) dispensing in Israel in 1997–2004
- 1 September 2005
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 16 (6) , 553
Nutritional rickets in children with cows' milk allergy: calcium deficiency or vitamin D deficiency?
- 1 September 2005
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 16 (6) , 553
Nutritional rickets in children with cows' milk allergy: calcium deficiency or vitamin D deficiency?
- 30 September 2004
- Published by Wiley in Pediatric Dermatology
- Vol. 21 (5) , 534-537
Eyelash Length in Children and Adolescents with Allergic Diseases
Abstract: Long eyelashes may be congenital, acquired in association with certain systemic diseases, or drug induced. In the past, long eyelashes were considered an external sign found in children with allergic diseases. However, this claim has never been examined in a controlled study. We compared the eyelash lengths of allergic children and adolescents with perennial allergic rhinitis, with or without bronchial asthma and atopic dermatitis (n = 60) to those of age‐ and sex‐matched nonallergic controls (n = 80). The eyelashes of the allergic patients were found to be significantly longer than those of the controls: 9.43 ± 1.39 mm versus 8.45 ± 1.30 mm (p < 0.001). Eyelash length did not differ between patients with allergic rhinitis only (n = 31; 9.65 ± 1.43 mm) and patients with allergic rhinitis and other allergic diseases (n = 29; 9.19 ± 1.31 mm) (p = 0.196). These results indicate that children and adolescents with allergic diseases have longer eyelashes compared to nonatopic controls and that long eyelashes may be a part of the phenotype of the allergic patient.
- 30 September 2004
- Published by Wiley in Pediatric Dermatology
- Vol. 21 (5) , 534-537
Eyelash Length in Children and Adolescents with Allergic Diseases
Abstract: Long eyelashes may be congenital, acquired in association with certain systemic diseases, or drug induced. In the past, long eyelashes were considered an external sign found in children with allergic diseases. However, this claim has never been examined in a controlled study. We compared the eyelash lengths of allergic children and adolescents with perennial allergic rhinitis, with or without bronchial asthma and atopic dermatitis (n = 60) to those of age‐ and sex‐matched nonallergic controls (n = 80). The eyelashes of the allergic patients were found to be significantly longer than those of the controls: 9.43 ± 1.39 mm versus 8.45 ± 1.30 mm (p < 0.001). Eyelash length did not differ between patients with allergic rhinitis only (n = 31; 9.65 ± 1.43 mm) and patients with allergic rhinitis and other allergic diseases (n = 29; 9.19 ± 1.31 mm) (p = 0.196). These results indicate that children and adolescents with allergic diseases have longer eyelashes compared to nonatopic controls and that long eyelashes may be a part of the phenotype of the allergic patient.
- 12 August 2003
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 14 (4) , 325-329
Food protein‐induced enterocolitis syndrome – not only due to cow's milk and soy
Over a of 7‐year period, six patients (four males, two females aged 3–12 months) were diagnosed with food protein‐induced enterocolitis syndrome (FPIES) triggered by foods other than cow's milk and soy: chicken in four, turkey in two, peas in one, and lentils in one (five patients reacted to more than one food type). All reactions developed within 2 h of ingestion of the allergenic food. To exclude other conditions with similar clinical symptoms, three infants underwent work‐up for sepsis, one infant underwent work‐up to exclude metabolic defects, and one underwent a barium enema to rule out intussusception. All were negative. Pediatricians should be aware that FPIES may be caused by foods other than cow's milk and soy, mainly chicken, turkey and foods from the legume family, and that it may present also in infants older than 6 months.
- 12 August 2003
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 14 (4) , 325-329
Food protein‐induced enterocolitis syndrome – not only due to cow's milk and soy
Over a of 7‐year period, six patients (four males, two females aged 3–12 months) were diagnosed with food protein‐induced enterocolitis syndrome (FPIES) triggered by foods other than cow's milk and soy: chicken in four, turkey in two, peas in one, and lentils in one (five patients reacted to more than one food type). All reactions developed within 2 h of ingestion of the allergenic food. To exclude other conditions with similar clinical symptoms, three infants underwent work‐up for sepsis, one infant underwent work‐up to exclude metabolic defects, and one underwent a barium enema to rule out intussusception. All were negative. Pediatricians should be aware that FPIES may be caused by foods other than cow's milk and soy, mainly chicken, turkey and foods from the legume family, and that it may present also in infants older than 6 months.
- Open Access
- 1 June 2003
- Published by BMJ in Archives of Disease in Childhood
- Vol. 88 (6) , 517-519
Chronic urticaria: association with thyroid autoimmunity
Background: Though autoimmune phenomena have been regularly associated with chronic urticaria in adults, data in children are sparse. Aim: To describe our experience with children and adolescents with chronic urticaria and autoimmunity. Methods and Results: Of 187 patients referred for evaluation of chronic urticaria during a 7.5 year period, eight (4.3%), all females aged 7–17 years, had increased levels of antithyroid antibody, either antithyroid peroxidase antibody (n = 4, >75 IU/ml), antithyroglobulin antibody (n = 2, >150 IU/ml), or both (n = 2). The duration of urticaria was four months to seven years. Five patients were euthyroid, one of whom was found to have increased antithyroid antibody levels five years after onset of the urticaria. One patient was diagnosed with Hashimoto thyroiditis three years before the urticaria, and was receiving treatment with thyroxine. Two other hypothyroid patients were diagnosed during the initial work up for urticaria (thyroxine 9.2 pmol/l, thyroid stimulating hormone (TSH) 40.2 mIU/l) and five years after onset of the urticaria (thyroxine 14 pmol/l, TSH 10.3 mIU/l). Both were treated with thyroxine but neither had remission of the urticaria. Five patients had a low positive titre of antinuclear antibodies. Conclusion: Children with chronic urticaria should be screened periodically for thyroxine, TSH, and antithyroid antibodies, as thyroid autoimmunity and hypothyroidism may appear several years after onset of the urticaria.
- 1 June 2003
- Published by BMJ in Archives of Disease in Childhood
- Vol. 88 (6) , 517-519
Open AccessChronic urticaria: association with thyroid autoimmunity
Background: Though autoimmune phenomena have been regularly associated with chronic urticaria in adults, data in children are sparse. Aim: To describe our experience with children and adolescents with chronic urticaria and autoimmunity. Methods and Results: Of 187 patients referred for evaluation of chronic urticaria during a 7.5 year period, eight (4.3%), all females aged 7–17 years, had increased levels of antithyroid antibody, either antithyroid peroxidase antibody (n = 4, >75 IU/ml), antithyroglobulin antibody (n = 2, >150 IU/ml), or both (n = 2). The duration of urticaria was four months to seven years. Five patients were euthyroid, one of whom was found to have increased antithyroid antibody levels five years after onset of the urticaria. One patient was diagnosed with Hashimoto thyroiditis three years before the urticaria, and was receiving treatment with thyroxine. Two other hypothyroid patients were diagnosed during the initial work up for urticaria (thyroxine 9.2 pmol/l, thyroid stimulating hormone (TSH) 40.2 mIU/l) and five years after onset of the urticaria (thyroxine 14 pmol/l, TSH 10.3 mIU/l). Both were treated with thyroxine but neither had remission of the urticaria. Five patients had a low positive titre of antinuclear antibodies. Conclusion: Children with chronic urticaria should be screened periodically for thyroxine, TSH, and antithyroid antibodies, as thyroid autoimmunity and hypothyroidism may appear several years after onset of the urticaria.